Skip to content

Advertisement

You're viewing the new version of our site. Please leave us feedback.

Learn more

BMC Complementary and Alternative Medicine

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Effect of oral administration of ethanolic extract of Vitex negundo on thioacetamide-induced nephrotoxicity in rats

  • Farkaad A Kadir1,
  • Normadiah M Kassim1Email author,
  • Mahmood A Abdulla2 and
  • Wageeh A Yehye3
Contributed equally
BMC Complementary and Alternative MedicineThe official journal of the International Society for Complementary Medicine Research (ISCMR)201313:294

https://doi.org/10.1186/1472-6882-13-294

Received: 14 April 2013

Accepted: 24 October 2013

Published: 30 October 2013

Abstract

Background

Oxidative stress due to abnormal induction of reactive oxygen species (ROS) molecules is believed to be involved in the etiology of many diseases. Evidences suggest that ROS is involved in nephrotoxicity through frequent exposure to industrial toxic agents such as thioacetamide (TAA). The current investigation was designed to explore the possible protective effects of the leaves of Vitex negundo(VN) extract against TAA-induced nephrotoxicity in rats.

Methods

Twenty four Sprague Dawley rats were divided into four groups: (A) Normal control, (B) TAA (0.03% w/v in drinking water), (C) VN100 (VN 100 mg/kg + TAA) and (D) VN300 (VN 300 mg/kg + TAA). Blood urea and serum creatinine levels were measured,supraoxide dismutase (SOD), catalase (CAT) and malondialdehyde (MDA) levels of renal tissue were assayed. Histopathological analysis together with the oxidative stress nicotinamide adenine dinucleotide phosphate (NADPH) oxidase p22phox in kidney sections were examined in all experimental groups.

Results

Blood urea and serum creatinine levels were increased in TAA group as a result of the nephrotoxicity compared to the VN100 and VN300 groups where, the levels were significantly decreased (p < 0.05). Renal MDA level was significantly decreased (p < 0.05) in the VN-treated groups with increased CAT and SOD activities compared to the TAA group. Light microscopic examination of renal tissues stained by H&E stain and Masson’s Trichrome for TAA-treated groups revealed severe histopathological changes, whereas specimens obtained from VN-treated groups showed only mild changes. These findings were supported by immunohistochemical results.

Conclusions

VN extract acts as a natural potent antioxidant to prevent ongoing TAA-induced nephrotoxicity in rats, both biochemically and morphologically.

Keywords

Vitex negundo ThioacetamideUreaCreatinineHistopathologyImmunohistochemistryNephrotoxicity

Background

Kidneys are highly vulnerable to damage caused by reactive oxygen species (ROSs), likely due to oxidative stress by polyunsaturated fatty acids in the composition of renal lipids [1]. This damage can also be caused by a high volume of blood flowing through it, and filtering large amounts of toxins, which can concentrate in kidney lobules [2]. The kidney’s response to toxicants varies by multiple morphological patterns beginning with tubular or interstitial changes to nephropathy [3]. It has been strongly implicated that (NADPH) oxidase, as a major source of ROSs production in the kidney [4] could have a role the in development of renal oxidative damage.

Nephrotoxicity is a poisonous effect due to drugs and its overdose on the kidneys. Thioacetamide (TAA) is an organic compound with the formula CH3CSNH2. It is originally used as a fungicide, and is a potent hepatotoxin [5]. It can serve as a source of sulphur in the synthesis of organic compounds such as rubber chemicals, curing agents, cross linking agents, metallurgy, pesticides, and pharmaceuticals [5]. TAA is the most potent nephrotoxic substance because of its rapid elimination and cumulative injury when it is given intermittently,presumably by free radical-mediated lipid [2, 6]. Metabolic studiesof TAA-induced tissue damage suggest that TAA is metabolized by the mixed function oxidase system to its toxic metabolites sulfine (sulfoxide) and sulfene (sulfone)which are then distributed among several organs,including plasma, liver, kidney, bone marrow, adrenals and other tissues [7]. Later, TAA undergoes an extensive metabolism to acetate and it is excreted through the urine within 24 hours [5, 8].

Vitex negundo (VN) is commonly called five leaved chaste tree. It is a large aromatic shrub or small and slender with quadrangular branchlets, about 2 to 5 m in height, distributed mainly in tropical to temperate regions, especially in Malaysia, India at the warmest zones and Western Himalayas [9].

The leaves have a typical five foliolate pattern in palmate arrangement measuring4-10 cm long and bluish purple in colour which become dark when ripened. The whole parts of the plant have shown to be a potent source of natural antioxidants [10], 1, 2 di-substituted idopyranose, the isolated compound from VN extract has shown protection of hepatocytes, nephrocytes and pancreatic β-cells in streptozotocin-induced diabetes, probably by its action against NF-kB and induced-nitric oxide synthase iNOS mediated inflammation [11]. A preliminary acute toxicity study of ethanolic leaf extract of VN in albino rats by oral rout carried out by Tandon, 2005 [12] found it to be practically nontoxic, as its LD50 dose was recorded as 7.58 g/Kg body weight with no histomorphological changes in liver, kidney, stomach, heart and lung at any dose of the extract studied.VN has various traditional uses in treating stomach-ache, eye disease, inflammation, enlargement of spleen, bronchitis, asthma and painful teething in children. It is also used as an antihelmintic, promoting hair growth [13], and the juice of the leaves used in treating ulcers and swelling of joints [14]. Literature review reveals that the plant of VN possesses analgesic and antinociceptive activity [15], hepatoprotective activity against TAA [16], antituberculardrugs [12], CCl4[17] and Ibuprofen via inhibition of lipid peroxidation [18].

In this study, VN extract was utilized in a rat model to evaluate its possible protective effects on TAA-induced nephrotoxicity. Data were collected on serum creatinine level, blood urea level, kidney and body weight ratio, glutathione content, and lipid peroxidation in the kidney tissues, as well as determination of p22phox expression and histopathological changes in the kidneys after administering VN extract in the adult male SD rats.

Methods

Collection and preparation of plant extract

Fresh leaves of VN plant were obtained from Kampung Baru, Sungai Ara, Penang, Malaysia. The botanical identity was determined and authenticated in the Department of Pharmacy, Faculty of Medicine, University Malaya, Kuala Lumpur, Malaysia with voucher specimen number (KLU 34968). The plant was dried and grounded to a fine powder. Next, the powder was homogenized in 95% ethanol at a ratio of 1:10 of plant to ethanol, and left to soak for four days at 25°C with occasional shaking and stirring. Later, the mixture was filtered through filter paper, and the resulting liquid was concentrated at a reduced pressure at 45°C to obtain a dark gummy–green extract. The percentage yield of VN crude extract was 18%. The extract was then dissolved in Tween 20 (10% w/v) and administered orally to rats in concentrations of 100 and 300 mg/kg body weight.

Preparation of TAA

TAA (from Sigma-Aldrich, Switzerland) and all other chemicals used were of analytical grade and purchased mostly from Sigma-Aldrich and Fisher. TAA stock solution was prepared by dissolving30 mg pure TAA which is in crystal form in 100 ml distilled water (0.03% w/v) until all the crystals were dissolved. The solution was given to the rats as their daily drinking water [19].

Experimental animals

A healthy adult male Sprague Dawley rats weighing 180–200 gm were obtained from the Animal House Unit, Faculty of Medicine, University of Malaya, Malaysia. They were kept in wire-bottomed cages at 25 ± 3°C, at 50–60% humidity, and a 12 h light-dark cycle for at least a week before the experiment. They were maintained under standard housing conditions with free access to a standard diet and water ad libitum during the experiment. The experimental protocol was approved by the Institutional Animal Care and Use Committee, University of Malaya (UM IACUC) with an ethical no. ANA/18/05/2012/FAAK. Throughout the experiment, all criteria for taking care of animals prepared by the National Academy of Sciences and outlined in the “Guide for the Care and Use of laboratory Animals” were compiled [20].

The animals were randomly divided into four experimental groups, with each group consisting of six rats, and given the following treatments: Group A: Normal control group, received per oral treatment of 10% Tween 20 (5 ml/kg) daily for 12 weeks; Group B: TAA group, received TAA 0.03% w/v in drinking water daily for 12 weeks; Group C: VN100 group, received TAA 0.03% w/v in drinking water and 100 mg/kg body weight of VN extract daily for 12 weeks; Group D: VN300 group,received TAA 0.03% w/v in drinking water and 300 mg/kg body weight of VN extract daily for 12 weeks.

The body weights of the animals were recorded weekly throughout the experimental period starting from Day 0. At the end of the 12th week, the rats were sacrificed 24 hours after the last treatment followed by overnight fasting. The rats were anaesthetized by intramuscular injection of 50 mg/kg ketamine mixed with xylazine 5 mg/kg. Blood samples were collected and serum was obtained for estimation of creatinine and blood urea levels. Kidney samples were dissected, trimmed of connective tissues, washed using normal saline to eliminate blood contamination, dried by blotting with filter paper and weighed. The kidneys were excised into two halves. One-half was kept in isotonic formalin for histopathological assessment and the other half was kept in the freezer under -80°C for preparing kidney homogenate for the malondialdehyde (MDA), catalase (CAT) and supraoxide dismutase(SOD) assays.

Assessment of renal function

A blood sample was withdrawn through the jugular vein and collected into a plain tube with activated gel for detection of urea and creatinine levels. The samples were allowed to clot, centrifuged and the serum samples were sent for analysis using a standard automated technique in the Central Diagnostic Laboratory (CDL), University of Malaya Medical Centre, according to the procedures described by the manufacturers.

Preparation of kidney homogenates

Kidney homogenates (10% w/v) were prepared by homogenizing kidney tissue in cold 50 mM potassium phosphate buffer saline (pH 7.4) using a tissue homogenizer (DAIHAN Sci., Seoul, Korea). The cell debris was removed by centrifugation at 4500 rpm for 15 minutes at 4°C using a refrigerated centrifuge Rotofix 32 (Hettich Zentrifugen, Germany). The supernatant was used for estimating the following in vivo antioxidant using commercially available kits (Cayman Chemical Company, USA): (MDA) or thiobarbituric acid reactive substance (TBARS) (Item No. 10009055), (CAT) (Item No. 707002) and (SOD) (Item No. 706002). All assays were performed according to the instruction manual of the manufacturers.

Histopathological assessment

The lower half of the right kidney was examined for histopathological changes. All kidneys specimens were examined under a light microscope. The kidneys were fixed in 10% formalin and then embedded in paraffin wax before sectioning at 5 μm thickness and stained with haematoxylin-eosin and Masson’s trichrome stains. Kidney sections from the six rats in each group were examined by two dependent observers. Morphological analysis there were carried out according to Houghton et al., [21] and were graded as follows: Grade 0 (normal), Grade 1 (when changes were limited to the tubulointerstitial areas of focal granulovascular epithelial cell degeneration and granular debris in the tubular lumina with or without evidence of desquamation in small foci (<1% of total tubule population involved by desquamation), Grade 2 (when tubular epithelial necrosis and desquamation were easily seen but involved less than half of the cortical tubules), Grade 3 (when more than half of the proximal tubules showing necrosis and desquamation, but with intact tubules easily identified, and Grade 4 (when there was complete or almost complete proximal tubular necrosis).

Immunohistochemical study

For the quantitative determination of anti-p22 phox antibody, immunohistochemistry kit for p22 phox (CS9): sc-130551 (Santa Cruz Biotechnology, INC.) was used. Briefly, sections were deparaffinized in xylene and hydrated in a series of graded alcohol. Deparaffinized sections were treated in a microwave oven in a citrate buffer at 95°C for 15 minutes, and immersed in 3% hydrogen peroxide in methanol for 10 min to abolish endogeneous peroxidase activities. The sections were immersed in normal goat serum for 15 min, incubated withmouse monoclonal antibody as a marker for NADPH oxidase subunits (diluted to 1:50) at 37°C for 60 min, and then incubated with goat anti-mouse IgG conjugated with horseradish\ peroxidise (HRP) (diluted to 1:200). The reaction products were visualized using 3-30-deiaminobenizidine tetrahydrochloride and hydrogen peroxide. A cytoplasmic brown granule was marked as positive expression of p22 phox.

Statistical analysis

All data were expressed as mean ± standard error of the mean (SEM) and statistical analysis was performed using SPSS for Windows version 17.0 (SPSS Inc. Chicago, IL, USA). One-way analysis of variance (ANOVA) followed by Bonferroni post hoc test was applied to test for statistically significant differences between groups at p < 0.05.

Results

Gross pathology

During the course of this study, continuous daily administration of 0.03% w/v TAA in drinking water was not associated with animal mortality. The external appearance of the kidneys from animals treated with TAA in drinking water as well as VN-treated groups revealed a smooth, glistening capsule with no petechial hemorrhage was noted.

Body and kidney weight

In the present study, the body weight of rats administered with TAA were reduced significantly (p < 0. 05) in comparison to the normal control group. Although there was increased in body weight of VN300 + TAA and VN100 + TAA groups, the increased in body weight was not significant (p < 0. 05) compared to TAA group. Concurrently, no noticeable concurrent significant difference in the weights of the kidneys for all groups was shown (Table 1).
Table 1

Effect of VN on body and kidney weights

Group

Body weight (g)

Kidney weight (g)

Normal control

219.8 ± 29.88**

0.95 ± 0.23

TAA

177.5 ± 7.1*

0.93 ± 0.119

VN100 + TAA

199.3 ± 15.98

0.94 ± 0.22

VN300 + TAA

204.3 ± 10.70

0.99 ± 0.29

Data were stated as mean ± SEM. Means with different superscripts are significantly different. * P < 0. 05 versus normal control group and ** P < 0. 05 versus TAA group.

Biochemical determination

Rats from the TAA-treated group exhibited significantly increased (p < 0. 05) levels of blood urea and serum creatinine compared to the normal control group. On the other hand increases in these parameters were prevented by concurrent treatment of animals with VN 100 mg/ kg, and more effectively, with VN 300 mg/kg which resulted in nearly normalized levels of these parameters (Table 2).
Table 2

Effect of VN on blood urea and serum creatininelevels

Group

Urea (mmol/L)

Creatinine (mol/L)

Normal control

4.46 ± 0.45**

23 ± 1.7**

TAA

8.73 ± 1.31*

52.3 ± 7.5*

VN100 + TAA

6.28 ± 0.59*,**

35.66 ± 7.3*,**

VN300 + TAA

5.73 ± 0.973**

29.33 ± 3.4**

Data were stated as mean ± SEM. Means with different superscripts are significantly different. * P < 0. 05 versus normal control group and ** P < 0. 05 versus TAA control group.

CAT and SOD are some of the enzymes of the intrinsic antioxidant defense system [22] which are responsible for the dissemination of free radicals such as superoxide radicals. Table 3 shows that SOD was significantly (p < 0.05) increased in high and low dose VN-treated groups but decreased in the TAA group due to long term excretion of free radicals. Generally, rats treated only with TAA, had significantly higher levels of MDA (p < 0.05) than normal rats and the other experimental treated groups. Notably, experimental rats treated with low dose and high dose VN extract had significantly lower levels (p < 0.05) of renal MDA compared to TAA group. These results suggest that treatment with VN extract may protect renal tissue from further damage.
Table 3

Effects of VN on some in vivo antioxidant parameters in all experimental groups

Group

CAT

SOD

MDA

 

(nmol/mg protein)

(U/mg protein )

(nmol/mg protien)

Normal control

27.24 ± 34.32

32.23 ± 7.14

38.74 ± 2.61

TAA

21.57 ± 24.87*

22.3 ± 8.58*

107.14 ± 3.71*

VN100 + TAA

24.75 ± 105.09

26.73 ± 0.93**

78.85 ± 2.26**

VN300 + TAA

25.26 ± 56.01

27.47 ± 3.44**

54.35 ± 1.73**

Data were stated as mean ± SEM. Means with different superscripts are significantlydifferent. * P < 0. 05 versus normal control group and ** P < 0. 05 versus TAA control group.

Histopathological findings

Histopathological examination of sections from rat kidneys treated with TAA showed impaired renal morphology throughout with severe and generalized tubular epithelial cell necrosis associated with diffuse tubular swelling, glomerular congestion and inflammatory cell infiltration. Kidneys from animals concurrently treated with VN 100 mg/kg body weight + TAA 0.03% in their drinking water showed mild to moderate inflammatory cell infiltration and tubular epithelial cell necrosis (Figure 1C), while concurrent treatment with VN 300 mg/kg body weight provided the best morphological protection against TAA-induced renal damage (Figure 1D and Figure 2D).
Figure 1

Photomicrographs of renal sections in all experimental groups. Ai: Normal control-cortical area, showing normal glomeruli (GL) with intact Bowman’s capsule (BM) and proximal convoluted tubules. Aii: Normal control-Medullary area, showing intact collecting ducts. B: TAA group-Cortical area, showing swollen and necrotic tubular cells, inflammatory cells infiltrate the GL and intertubular area and thinning-out of the BM. C: VN 100 group- Cortical area exhibiting mild tubular epithelial changes with intratubular casts and mild intertubular inflammatory cells infiltration and GL look normal. D: VN 300 group - Cortical area, showing both GL and renal tubules appearing normal. H & E stain. Bar = 100 μm.

Figure 2

Photomicrographs of renal sections stained with Masson’s trichrome of the different groups. A: Normal control, showing normal glomeruli (GL) in the cortical area, with intact Bowman’s capsule (BM) and proximal convoluted tubules. B: TAA group, showing renal cortical tissue with swollen and necrotic tubular cells, C: VN100 group, showing mild tubular epithelial changes in renal cortical tissue. D: VN300 group, showing renal cortical tissue with both GL and tubules appearing normal. Bar = 100 μm.

Discussion

Various useful drugs like acetaminophen, gentamicin and some environmental and industrial toxicants can cause severe renal damage through activation of these drugs to highly reactive free radicals [23]. One of the most extensively studied chemicals and industrial toxicants is TAA. TAA is known to induce centrilobular hepatic necrosis, liver cirrhosis, hepatocellular carcinoma and bile duct proliferation [5, 8, 16, 24, 25] with injury to the terminal portion of the proximal renal tubule [7]. After administration of TAA, this chemical undergoes an extensive metabolism forming sulfine (sulfoxide) and sulfene (sulfone). Both are circulated through several vital organs in body before finally being transformed into acetate and excreted into urine within 24 hours [8].

TAA administration (0.03% w/v) in drinking water for 12 weeks found to cause renal toxicity as assessed by biochemical analysis of urea and creatinine, MDA and antioxidant status of SOD and CAT. As a measure of renal function status, blood urea and creatinine are often regarded as reliable markers [26]. The increased urea and creatinine levels resulting from TAA administration in this study (Table 2), are in agreement with a previous study done by Begum et al., [2]. High values of blood urea and serum creatinine indicate renal damage [27, 28] and this may be correlated with the significant and progressive weight loss in the TAA group (Table 1). As for the VN100 and VN300 groups, although there was increased body weight in both groups, the increase was not significantly different compared in the TAA group (Table 1).

From this study, pretreatment with VN 100 mg/kg extract could partly prevent TAA-induced kidney damage as shown by the decreasing levels of urea and creatinine. These parameters were almost significantly normalized by the administration of VN 300 mg/kg extract (Table 2). This result is consistent with many previous studies done using other traditional plants [29], and is strongly attributed to the scavenging free radicals and reduced lipid peroxidation mechanisms.

Free radicals are believed to play a major role in the development of TAA-induced toxicity [30], hence, when oxidative stress is overwhelming, the various inherent defense mechanisms such as the antioxidant defense mechanisms, intercellular concentration of CAT and SOD activities become significantly impaired and insufficient [31]. This is because during oxidative stress, the body uses its defense mechanism to minimize the process of lipid peroxidation using these antioxidant enzymes, thus, the activity of these enzymes becomes higher in early stages of TAA induction. When the oxidative insult was continued for a long period, the enzymes become depleted and unable to fight against the free radicals, suggesting advance stages of TAA-induced peroxidation. This was evident in the present study with the significant increase (p < 0. 05) in MDA level, renal damage in TAA group compared to the normal control group.

Several phytochemical studies have revealed the presence of volatile oils, lignans, flavonoid like flavones, luteolin-7-glucoside and glycosides in VN [9]. In addition, VN ethanolic extract possesses radical scavenging activity probably due to higher concentration of flavonoids and alkaloids [32]. This was evident in the increased (CAT and SOD) levels in this study as well as the decreased in MDA level in the VN- treated groupsas shown in Table 3. Presumably, this is due to the antioxidant properties of the plant extract, which may account for the nephroprotective action of VN against TAA-induced nephrotoxicity experimental models.

TAA is toxic to selected populations of cells (hepatocytes, proximal convoluted tubular cells in kidney and cortical thymocytes) [7], and several animals studies have shown that toxin-induced renal tubular damage plays a crucial role in the reduction of glomerular filtration rate either through obstruction and back leak of renal filtrate or secondary to ROS [33]. The p22phox is one of the subunits of the NADPH oxidase which generates ROS that plays an important role in the development of many kidney diseases [4, 34]. Thus, VN is important in protecting the kidney from TAA-induced injury, through the improvement in renal function and antioxidant status. Furthermore, these findings were corroborated by the renal histological and immunohistochemical results, which revealed more extensive and marked tubular and glomerular damage with apparent expression of p22phox protein in the TAA-treated group. Similar changes were also reported by Edward et al., [7] demonstrating structural changes in renal tissue. However, in the VN-treated groups, renal microscopic changes were alleviated and the renal histological architecture was almost normalised, especially, at the maximum dose of 300 mg/kg as shown in Figures 1, 2, 3 and Table 4. Although the exact mechanism of TAA-induced nephrotoxicity is not well understood, but based on several previous studies [27, 28, 35, 36] we can postulate that the protective effect of VN extract is via its antioxidant and/or free radical scavenging activities due to its high concentration of flavonoids and alkaloids content [9].
Figure 3

Photomicrographs of renal sections for immunohistochemical evaluation of 22phox protein expression in all experimental groups. A: Normal control, showing normal glomerulus (GL) in the cortical area, with intact Bowman’s capsule (BM) and normal tubulointerstitium. B: TAA group showed p22phox was markedly expressed in glomerulus and interstitium, C: VN100 and D: VN300 groups, showed marked reduction in p22phox protein expression. Bar = 50 μm.

Table 4

Histopathological grading of the kidney sections for all experimental groups

Pathological grading

Group

N

0

I

II

III

IV

Average of grades

Normal

6

6

0

0

0

0

0.0**

TAA

6

0

0

0

2

4

3.33 ± 0.51*

VN 100 + TAA

6

0

1

1

4

0

2.00 ± 0.63**

VN 300 + TAA

6

1

3

2

0

0

1.16 ± 1.34**

Data were stated as mean ± SEM. Means with different superscripts are significantly different. * P < 0. 05 versus normal control group and ** p < 0. 05 versus TAA control group.

Conclusions

The overall results from this study demonstrated TAA-induced renal injury by biochemical analysis, histopathological features and immunohistochemistry analysis. The concurrent treatment with VN extract clearly provided a considerable degree of protection in a dose-dependent manner against the deleterious renal side effects of TAA. In conclusion, VN could act on the kidney as a potent natural antioxidant to prevent ongoing TAA- induced nephrotoxicity, thus, these results constitute a lead towards discovering a novel herb in traditional and complementary medicine.

Notes

Declarations

Acknowledgments

The authors express their gratitude to the staffs of the Faculty of Medicine, Animal House for the care and supply of rats. Financial support from (PG087-2012B) and (UM/MoHE/HIR Grant E000045-20001) from University of Malaya, Malaysia, are gratefully acknowledged.

Authors’ Affiliations

(1)
Department of Anatomy, Faculty of Medicine, University of Malaya
(2)
Department of Biomedical Science, Faculty of Medicine, University of Malaya
(3)
Nanotechnology & Catalysis Research Centre, (NANOCAT), University of Malaya, Block 3A, Institute of Postgraduate Studies Building

References

  1. Ozbek E: Induction of Oxidative Stress in Kidney. Int J Nephrol. 2012, 2012: 1-9.View ArticleGoogle Scholar
  2. Begum Q, Noori S, Mahboob T: Antioxidant effect of sodium selenite on thioacetamide-induced renal toxicity. Pakistan Journal of Biochemistry and Molecular Biology. 2011, 44 (1): 21-26.Google Scholar
  3. Silva FG: Chemical-induced nephropathy: a review of the renal tubulointerstitial lesions in humans. Toxicol Pathol. 2004, 32 (2): 71-84.View ArticlePubMedGoogle Scholar
  4. Etoh T, Inoguchi T, Kakimoto M, Sonoda N, Kobayashi K, Kuroda J, Sumimoto H, Nawata H: Increased expression of NAD (P) H oxidase subunits, NOX4 and p22phox, in the kidney of streptozotocin-induced diabetic rats and its reversibity by interventive insulin treatment. Diabetologia. 2003, 46 (10): 1428-1437. 10.1007/s00125-003-1205-6.View ArticlePubMedGoogle Scholar
  5. Kadir FA, Othman F, Abdulla MA, Hussan F, Hassandarvish P: Effect of Tinospora crispa on thioacetamide-induced liver cirrhosis in rats. Indian J Pharmacol. 2011, 43 (1): 64-68. 10.4103/0253-7613.75673.View ArticlePubMedPubMed CentralGoogle Scholar
  6. Dashti HM, Mathew TC, Jadaon MM, Ashkanani E: Zinc and liver cirrhosis: biochemical and histopathologic assessment. Nutrition. 1997, 13 (3): vi-212.View ArticleGoogle Scholar
  7. Edward A, Baker EAS: Nonhepatic Thioacetamide Injury. The morphologic Features of proximal renal tubular injury. Am J Pathol. 1974, 74 (3): 576-590.Google Scholar
  8. Spira B, Raw I: The effect of thioacetamide on the activity and expression of cytosolic rat liver glutathione-S-transferase. Mol Cell Biochem. 2000, 211 (1): 103-110.View ArticlePubMedGoogle Scholar
  9. Gautam L, Shrestha S, Wagle P, Tamrakar B: Chemical constituents from Vitex negundo (Linn.) of nepalese origin. Scientific world. 2010, 6 (6): 27-32.View ArticleGoogle Scholar
  10. Raghavendra H, Lakshmanashetty VBN, Madhumathi G, Hiremath aVK: In vitro Antioxidant Activity of Vitex negundo L. Leaf Extracts. Chiang Mai Journal of Science. 2010, 37 (3): 489-497.Google Scholar
  11. Manikandan R, Thiagarajan R, Beulaja S, Sivakumar MR, Meiyalagan V, Sundaram R, Arumugam M: 1,2 di-substituted idopyranose from Vitex negundo L. protects against streptozotocin-induced diabetes by inhibiting nuclear factor-kappa B and inducible nitric oxide synthase expression. Microsc Res Tech. 2011, 74 (4): 301-307.PubMedGoogle Scholar
  12. Tandon VR: Medicinal uses and biological activities of Vitex negundo. Natural product radiance. 2005, 4 (3): 162-165.Google Scholar
  13. Singh P, Mishra G, Srivastava S, Sangeeta K, Khosa R: Phytopharmacological review of vitex negundo (Sambhalu). Pharmacologyonline. 2011, 2: 1355-1385.Google Scholar
  14. Nadkarni KM: Dr. K. M. Nadkarni&s Indian materia medica. 1. 1994, Popular PrakashanGoogle Scholar
  15. Zheng C-J, Huang B-K, Han T, Zhang Q-Y, Zhang H, Rahman K, Qin L-P: Antinociceptive activities of the liposoluble fraction from Vitex negundo seeds. Pharm Biol. 2010, 48 (6): 651-658. 10.3109/13880200903241838.View ArticlePubMedGoogle Scholar
  16. Kadir FA, Kassim NM, Abdulla MA, Yehye WA: Hepatoprotective Role of Ethanolic Extract of Vitex negundo in Thioacetamide-Induced Liver Fibrosis in Male Rats. Evidence-Based Complementary and Alternative Medicine. 2013, 2013:Google Scholar
  17. Avadhoot Y, Rana A: Hepatoprotective effect of Vitex negundo against carbon tetrachloride-induced liver damage. Arch Pharm Res. 1991, 14 (1): 96-98. 10.1007/BF02857823.View ArticlePubMedGoogle Scholar
  18. Mahalakshmi R, Rajesh P, Balasubramanian V, Rajesh Kanan V: Hepatoprotective activity on Vitex negundo Linn.(Verbanaceae) by using Wistar albino rats in Ibuprofen induced model. Int J Pharmacol. 2010, 6 (5): 658-663.View ArticleGoogle Scholar
  19. Müller A, Machnik F, Zimmermann T, Schubert H: Thioacetamide-induced cirrhosis-like liver lesions in rats usefulness and reliability of this animal model. Exp Pathol. 1988, 34 (4): 229-236. 10.1016/S0232-1513(88)80155-5.View ArticlePubMedGoogle Scholar
  20. National research council. Guide for the care and use of laboratory animals. Washington, DC: The National Academies Press, 8Google Scholar
  21. Houghton DC, Plamp CE, DeFehr JM, Bennett WM, Porter G, Gilbert D: Gentamicin and tobramycin nephrotoxicity. a morphologic and functional comparison in the rat. Am J Pathol. 1978, 93 (1): 137-152.PubMedPubMed CentralGoogle Scholar
  22. Ercal N, Gurer-Orhan H, Aykin-Burns N: Toxic metals and oxidative stress part I: mechanisms involved in metal-induced oxidative damage. Curr Top Med Chem. 2001, 1 (6): 529-539. 10.2174/1568026013394831.View ArticlePubMedGoogle Scholar
  23. Olagunju J, Adeneye A, Fagbohunka B, Bisuga N, Ketiku A, Benebo A, Olufowobi O, Adeoye A, Alimi M, Adeleke A: Nephroprotective activities of the aqueous seed extract of Carica papaya Linn. in carbon tetrachloride induced renal injured Wistar rats: a dose-and time-dependent study. Biol Med. 2009, 1 (1): 11-19.Google Scholar
  24. Stankova P, Kucera O, Lotkova H, Rousar T, Endlicher R, Cervinkova Z: The toxic effect of thioacetamide on rat liver in vitro. Toxicol In Vitro. 2010, 24 (8): 2097-2103. 10.1016/j.tiv.2010.06.011.View ArticlePubMedGoogle Scholar
  25. Madani H, Talebolhosseini M, Asgary S, Naderi G: Hepatoprotective activity of Silybum marianum and Cichorium intybus against thioacetamide in rat. Pakistan J Nutr. 2008, 7 (1): 172-176. 10.3923/pjn.2008.172.176.View ArticleGoogle Scholar
  26. Gowda S, Desai PB, Kulkarni SS, Hull VV, Math AAK, Vernekar SN: Markers of renal function tests. North Am J Med Sci. 2010, 2 (4): 170-Google Scholar
  27. Adeneye AA, Benebo AS: Protective effect of the aqueous leaf and seed extract of Phyllanthus amarus on gentamicin and acetaminophen-induced nephrotoxic rats. J Ethnopharmacol. 2008, 118 (2): 318-323. 10.1016/j.jep.2008.04.025.View ArticlePubMedGoogle Scholar
  28. Khalid MS: Nephroprotective effect of the ethanolic extract of Lantana camara Linn flower on acute dose of Cisplatin induced renal injured rats. 2012Google Scholar
  29. El-Adawi H, El-Azhary D, Abd El-Wahab A, El-Shafeey M, Abdel-Mohsen M: Protective effect of milk thistle and grape seed extracts on fumonisin B1 induced Hepato-and nephro-toxicity in rats. J Med Plant Res. 2011, 5 (27): 6316-6327.View ArticleGoogle Scholar
  30. Mohammed AA, Mahmood Ameen A, Salmah I, Zahra AA: Hepatoprotective effects of Orthosiphon stamineus extract on thioacetamide-induced liver cirrhosis in rats. Evidence-Based Complementary and Alternative Medicine. 2011, 2011:Google Scholar
  31. Parlakpinar H, Tasdemir S, Polat A, Bay-Karabulut A, Vardi N, Ucar M, Acet A: Protective role of caffeic acid phenethyl ester (cape) on gentamicin-induced acute renal toxicity in rats. Toxicology. 2005, 207 (2): 169-177. 10.1016/j.tox.2004.08.024.View ArticlePubMedGoogle Scholar
  32. Tiwari OP, Tripathi YB: Antioxidant properties of different fractions of Vitex negundo Linn. Food Chemistry. 2007, 100 (3): 1170-1176. 10.1016/j.foodchem.2005.10.069.View ArticleGoogle Scholar
  33. Leena P, Balaraman R: Effect of green tea extract on cisplatin induced oxidative damage on kidney and testes of rats. Ars Pharmaceutica. 2005, 46: 5-18.Google Scholar
  34. Hu Z, Ren L, Wang C, Liu B, Song G: Effect of chenodeoxycholic acid on fibrosis, inflammation and oxidative stress in kidney in high-fructose-fed wistar rats. Kidney Blood Press Res. 2012, 36 (2): 85-97. 10.1159/000341485.View ArticlePubMedGoogle Scholar
  35. Sarumathya K, Vijay T, Jayakanthia J, Dhana M: A protective effect of Caesalpinia sappan (CS) on acetaminophen induced nephrotoxicity and oxidative stress in male albino rats. J Pharmacol Toxicol. 2011, 2: 11-21.Google Scholar
  36. Khan SA, Priyamvada S, Khan W, Khan S, Farooq N, Yusufi ANK: Studies on the protective effect of green tea against cisplatin induced nephrotoxicity. Pharmacol Res. 2009, 60 (5): 382-391. 10.1016/j.phrs.2009.07.007.View ArticlePubMedGoogle Scholar
  37. Pre-publication history

    1. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6882/13/294/prepub

Copyright

© Kadir et al.; licensee BioMed Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement